Myasthenia gravis and pregnancy

Clinical Obstetrics and Gynecology

Volumn 56, Issue 2, 2013, Pages 372-381

  Varner, Michael ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylcholine esterase inhibitors; Myasthenia gravis; Myasthenic crisis; Neonatal myasthenia

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; EDROPHONIUM CHLORIDE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MATERNAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEOSTIGMINE; PYRIDOSTIGMINE; QUINIDINE; RITUXIMAB;

ABDOMINAL CRAMP; ARTICLE; BREAST FEEDING; CESAREAN SECTION; COMPUTER ASSISTED TOMOGRAPHY; CONTRACEPTION; CORTICOSTEROID THERAPY; DELIVERY; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; EPIPHORA; FLATULENCE; HUMAN; HUMAN EXPERIMENT; HYPERSALIVATION; HYPERTENSION; LABOR; LIMB WEAKNESS; MONOCULAR VISION; MYASTHENIA GRAVIS; NAUSEA; NEPHROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PLASMAPHERESIS; POSITRON EMISSION TOMOGRAPHY; PREGNANCY; REMISSION; THYMECTOMY; TREATMENT CONTRAINDICATION; VOMITING;

FEMALE; HUMANS; INFANT, NEWBORN; MYASTHENIA GRAVIS; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84877576509     PISSN: 00099201     EISSN: 15325520     Source Type: Journal    
DOI: 10.1097/GRF.0b013e31828e92c0     Document Type: Article

References (50)

1. Mays J, Butts CL. Intercommunication between the neuroendocrine and immune systems: focus on myasthenia gravis. Neuroimmunomodulation. 2011;18:320-327.
2. Phillips LH 2nd. The epidemiology of myasthenia gravis. Ann NY Acad Sci. 2003;998:407-412.
3. Drachman D. Myasthenia gravis. N Engl J Med. 1994;330:1797-1810.
4. Juel VC, Massey JM. Myasthenia gravis. Orphanet J Rare Dis. 2007;2:44.
5. Howard JF, Sanders DB, Massey JM. The electrodiagnosis of myasthenia gravis and the Lambert- Eaton myasthenic syndrome. Neurol Clin. 1994;12:305-330.
6. Lindstrom JM, Seybold ME, Lennon VA, et al. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology. 1976;26:1054-1059.
7. Newsom-Davis J. The emerging diversity of neuromuscular junction disorders. Acta Myologica. 2007;XXVI:5-10.
8. Vincent A, McConville J, Farrugia ME, et al. Seronegative myasthenia gravis. Sem Neurol. 2004;24:125-133.
9. Evoli A, Tonali PA, Padua L, et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain. 2003;126:2304-2311.
10. Leite MI, Strobel P, Jones M, et al. Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG. Ann Neurol. 2005;57:444-448.
11. Mao ZF, Mo XA, Qin C, et al. Incidence of thymoma in myasthenia gravis: a systematic review. J Clin Neurol. 2012;8:161-169.
12. Buckley C, Douek D, Newson-Davis J, et al. Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis. Ann Neurol. 2001;50:64-72.
13. Titulaer MJ, Soffietti R, DalmauJ, et al. Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol. 2011;18: 19-e3. 10.1111/j.1468-1331.2010.03220.x.
14. Tomiyama N, Honda O, Tsubamoto M, et al. Anterior mediastinal tumors: diagnostic accuracy of CT and MRI. Eur J Radiol. 2009;69:280-288.
15. El-Bawab H, Al-Sugair AA, Rafay M, et al. Role of fluorine-18 fluorodeoxyglucose positron emission tomography in thymic pathology. Eur J Cardiothorac Surg. 2007;31:731-736.
16. Chagnac Y, Hadanin M, Goldhammer Y. Myasthenic crisis after intervenous administration of iodinated contrast agent. Neurology. 1985;35: 1219-1220.
17. Eden RD, Gall SA. Myasthenia gravis and pregnancy. A reappraisal of thymectomy. Obstet Gynecol. 1983;62:328-333.
18. Hoff JM, Daltveit AK, Gilhus NE. Myasthenia gravis in pregnancy and birth: identifying risk factors, optimizing care. Eur J Neurol. 2007;14: 38-43.
19. Ramirez C, deSeze J, Delrieu O, et al. Myasthenia gravis and pregnancy: clinical course and management of delivery and the postpartum phase. Rev Neurol. 2006;162:330-338.
20. Engel AG, Sine SM. Current understanding of congenital myasthenic syndromes. Curr Opin Pharmacol. 2005;5:308-321.
21. Beeson D. Congenital myasthenic syndromes. Adv Clin Neurosci Rehabil. 2005;4:12-13.
22. Hantai D, Richard P, Koenig J, et al. Congenital myasthenic syndromes. Cur Opin Neurol. 2004;17: 539-551.
23. Batocchi AP, Majolini L, Evoli A, et al. Course and treatment of myasthenia gravis during pregnancy. Neurology. 1999;52:447-452.
24. Plauche WC. Myasthenia gravis. Clin Obstet Gynecol. 1983;26:592-604.
25. Ferrero S, Pretta S, Nicoletti A, et al. Myasthenia gravis: management issues during pregnancy. Eur J Obstet Gynecol. 2005;12:129-138.
26. Brenner T, Byeth Y, Abramsky O. Inhibitory effect of alpha fetoprotein on the binding of myasthenia gravis antibody to acetylcholine receptor. Proc Natl Acad Sci USA. 1980;77: 3635-3639.
27. Hoff JM, Daltveit AK, Gilhus NE. Myasthenia gravis: consequences for pregnancy, delivery, and the newborn. Neurology. 2003;61:1362-1366.
28. Mantegazza R, Bonanno S, Camera G, et al. Current and emerging therapies for the treatment of myasthenia gravis. Neuropsych Dis Treat. 2011;7:151-160.
29. Johns TR. Long-term corticosteroid treatment of myasthenia gravis. 1987;505:568-583.
30. Schneider-Gold C, Gajdos P, Toyka KV, Corticosteroids for myasthenia gravis. Cochrane Database Syst Rev, 2005: CD002828.
31. Chaudhry SA, Bignarajah B, Koren G. Myasthenia gravis during pregnancy. Can Fam Physician. 2012;58:1346-1349.
32. Goldstein LH. Pregnancy outcome of women exposed to azathioprine during pregnancy. Birth Defects Res A Clin Mol Teratol. 2007;79:696-701.
33. Angelberger S, Reinishch W, Messerschmidt A, et al. Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding. J Crohns Colitis. 2011;5:95-100.
34. Evans WE, McLeod HL. Pharmacogenomics- drug disposition, drug targets, and side effects. N Engl J Med. 2003;348:538-549.
35. Nulman I, Sgro M, Barrera M, et al. Long-term neurodevelopment of children exposed in utero to cyclosporine after maternal renal transplant. Pediatric Drugs. 2010;12:113-122.
36. Tindall RS,Rollins JA, Phillips JT, et al. Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis. N Engl JMed. 1098;316:719-724.
37. Hart IK, Sathasivam S, Sharshar T. Immunosuppresive agents for myasthenia gravis. Cochrane Database Syst Rev, 2007: CD005224.
38. Gajdos P, Tranchant C, Clair B, et al. Myasthenia gravis clinical study group. Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin; a randomized double-blind clinical trial. Arch Neurol. 2005;62:1689-1693.
39. Cortese I,ChaudhryV, SoYT, et al.Evidence-based guideline update: plasmapheresis in neurologic disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2011;76:294-300.
40. Mao ZF, Yang LX, Mo XA, et al. Frequency of autoimmune diseases in myasthenia gravis: a systematic review. Int J Neurosci. 2011;121:121-129.
41. Cohen BA, London RS, Goldstein PJ. Myasthenia gravis and preeclampsia. Obstet Gynecol. 1976;48:35S-37S.
42. Stafford IP, Dildy GA. Myasthenia gravis and pregnancy. Clin Obstet Gynecol. 2005;48: 48-56.
43. Stoll C, Ehret-Mentre MC, Treisser A, et al. Prenatal diagnosis of congenital myasthenia with arthrogryposis in a myasthenic mother. Prenatal Diagnosis. 1991;11:17-22.
44. Chaudhuri A, Behan PO. Myasthenic crisis. QJM. 2009;102:97-107.
45. Servais L, Baudoin H, Zehrouni K, et al. Pregnancy in congenital myasthenic syndrome. J Neurol. 2013;260:815-819.
46. Donaldson JO, Penn AS, Lisak RP. Antiacetylcholine receptor antibody in neonatal myasthenia gravis. Am J Dis Child. 1981;135:222-226.
47. Lefvert AK, Osterman PO. Newborn infants to myasthenic mothers: a clinical study and an investigation of acetylcholine receptor antibodies in 17 children. Neurology. 1983;33:133-138.
48. Riemersma S, Vincent A, Beeson D, et al. Association of arthrogryposis multiplex congenital with maternal antibodies inhibiting fetal acetylcholine receptor function. J Clin Invest. 1996;98: 2358-2363.
49. How dangerous is the pill? Z Allgemeinmed. 1975;20:1156-1157.
50. Stickler DE, Stickler LL. Single-fiber electromyography during menstrual exacerbation and ovulatory suppression in MuSK antibody-positive myasthenia gravis. Muscle Nerve. 2007;35: 808-811.